Advertisement

Related Videos

Peter Clark, MA, MD, FRCP: A Payer Perspective

Deborah Collyar: What's In It for Patients?

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Amit Sanyal, MD: A Clinician’s Perspective

Advertisement

Advertisement




May
24
Today In Oncology
Inavolisib-Based Regimen in PIK3CA-Mutated, HR-Positive, HER2-Negative Advanced Breast Cancer
GLP-1 RAs May Lower Risk of Obesity-Related Cancers
Extensive-Stage SCLC Lurbinectedin and Atezolizumab
Use of AI Assistance to Improve HER2 Breast Cancer Classifications
WGS Liquid Biopsies for HPV-Associated Head and Neck Squamous Cell Carcinoma
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo